Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Did Meta’s Big Settlement Actually Help It?
The tech giant’s landmark deal with states over teen use of social media may cost the company less than expected. It may...
What the Buss family Lakers dispute can teach the wealthy about trusts
A version of this article first appeared in CNBC's Inside Wealth newsletter with Robert Frank, a weekly guide to th...
Much-loved ice cream shop to close after 106 years
Much-loved ice cream shop to close after 106 yearsTo play this video you need to enable JavaScript in your browser.This ...
Best Buy tops quarterly estimates, raises outlook as computing shows strength
Best Buy on Thursday reported better-than-expected fiscal second-quarter results and raised its full-year outlook as the...